Ratnakar Lavu - 01 Mar 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Chief Digital Officer
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2024, 16:28:24 UTC
Previous filing: 09 Feb 2024
Next filing: 05 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Award	$0	+1,754		$0.000000	1,754	01 Mar 2024	Direct	F1
transaction	ELV	Common Stock	Award	$0	+1,002	+57%	$0.000000	2,756	01 Mar 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+6,765		$0.000000	6,765	01 Mar 2024	Common Stock	6,765	$499.11	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units. Restrictions lapse as follows: 584 shares on 3/1/2025, and 585 shares each on 3/1/2026 and 3/1/2027.
F2	Represents restricted share units. Restrictions lapse as follows: 501 shares each on 3/1/2025 and 3/1/2026.
F3	The option represents a right to purchase a total of 6,765 shares, and is exercisable in three annual installments of 2,255 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.